Miaoyi Biotechnology is an innovative CRO technology platform in the field of pharmaceutical research and development, and is a highly influential and youthful company in the Chinese market.

The company is positioned to solve common key pain points for the industry, focusing on the goal of making pharmaceutical research and development more efficient. It implements the core strategy of "one body, two wings", which is based on innovative industry talent supply models, data empowerment and technology driven wings. It independently develops a full chain clinical research SaaS solution, accumulates comprehensive clinical research data capabilities, and creates a unique "T4S service system". By innovating through industrial digitization, we can effectively reduce pharmaceutical research and development costs, accelerate clinical research cycles, and stabilize delivery quality.

The business scope covers CRO services such as clinical monitoring, project management, registration affairs, biostatistics, drug vigilance, medical affairs, SMO services such as center on-site management, patient recruitment and management, FSP services for clinical research talent dispatch, as well as intelligent data products and SaaS services.

Representative products under the company include: Trial Link platform, Drug Research Society APP, Health Secretary APP, MY-TDC, Jianyan APP, etc.

Displaying products/services/technologies

Innovative CRO, Innovative SMO, Intelligent Data Services, Center Quick Start SSU, Temporary Research SaaS Services, Talent Dispatch (FSP)

Official website: yaoyanshe.com